As of June 13, 2025, MJardin Group Inc (MJAR.CN) reports a EV/EBITDA of -5.32.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing MJardin Group Inc's EV/EBITDA to Peers
To better understand MJardin Group Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| MJardin Group Inc (MJAR.CN) | -5.32 |
| Cipher Pharmaceuticals Inc (CPH.TO) | 26.40 |
| Aoxing Pharmaceutical Company Inc (AOXG) | 10.76 |
| Vext Science Inc (VEXT.CN) | 3.58 |
| Captor Capital Corp (CPTR.CN) | 0.48 |
| Sonoma Pharmaceuticals Inc (SNOA) | 0.03 |
Compared to its competitors, MJardin Group Inc's EV/EBITDA is among the lowest compared to peers, which may indicate undervaluation or market concerns about future performance.